IMUC
ImmunoCellular Therapeutics, Ltd.
IMUC
IMUC
Delisted
IMUC was delisted on the 16th of October, 2018.
39 hedge funds and large institutions have $3.49M invested in ImmunoCellular Therapeutics, Ltd. in 2013 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
60% less capital invested
Capital invested by funds: $8.67M → $3.49M (-$5.18M)
Holders
39
Holding in Top 10
–
Calls
$789K
Puts
$938K
Top Buyers
| 1 | +$128K | |
| 2 | +$112K | |
| 3 | +$111K | |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$107K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$99.1K |
Top Sellers
| 1 | -$318K | |
| 2 | -$201K | |
| 3 | -$97.5K | |
| 4 |
BG
BlackRock Group
London,
United Kingdom
|
-$92K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$69.5K |